Performing Cardiac Magnetic Resonance Imaging in Patients With Cardiac Implantable Electronic Devices: A Contemporary Review

Can J Cardiol. 2018 Dec;34(12):1682-1686. doi: 10.1016/j.cjca.2018.09.009. Epub 2018 Sep 29.

Abstract

There are expanding indications for cardiac magnetic resonance imaging (CMR) in patients with cardiac implantable electronic devices (CIEDs). The presence of a CIED had been regarded as a contraindication to CMR due to concerns of arrhythmias, significant changes to lead parameters, and detrimental changes to device programming. The risk of these potential adverse events is theoretically higher in patients undergoing CMR as compared with other anatomic sites. Recent studies have observed low rates of adverse events in patients undergoing CMR (< 1% to 2%), prompting a shift in the recommendations on CMR in patients with CIEDs. The 2017 Heart Rhythm Society Expert Consensus Statement now states that CMR can be performed in patients with both conditional and nonconditional CIEDs at a magnetic strength of 1.5 T, provided there are no fractured, abandoned, or epicardial leads and modifications to MRI parameters are made. The purpose of this review is to (a) outline the potential concerns of performing CMR in patients with CIEDs, (b) define categories of CIEDs as they pertain to MRI safety, (c) summarize the emerging data on adverse events, and (d) provide a practical approach, integrating the key modifications required to perform CMR in patients with CIEDs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Consensus Development Conferences as Topic
  • Contraindications
  • Defibrillators, Implantable*
  • Humans
  • Magnetic Resonance Imaging* / adverse effects
  • Magnetic Resonance Imaging* / methods
  • Pacemaker, Artificial*